Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Fondazione Michelangelo | Researchclopedia

Back to institutions

Fondazione Michelangelo

Milannonprofit

147

Works

20,302

Citations

46

h-index

Top Research Topics

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Cancer Immunotherapy and Biomarkers

Top Researchers

Eric P. Winer Harvard University

1,618 works128,867 citationsh-index: 170

Recent Research

Toxicity impacts evolution in the Environmental Footprint methods: an example-based interpretation of the results

Fabrizio Biganzoli,Esther Sanyé Mengual,et al.

20260 citations

Cancer Treatment and Pharmacology

Cancer Genomics and Diagnostics

Advanced Breast Cancer Therapies

Monoclonal and Polyclonal Antibodies Research

Cancer Cells and Metastasis

Chronic Lymphocytic Leukemia Research

Lymphoma Diagnosis and Treatment

Peptidase Inhibition and Analysis

Immunotherapy and Immune Responses

Norman Wolmark NSABP Foundation

823 works121,738 citationsh-index: 143

Giuseppe Viale European School of Oncology

1,261 works112,802 citationsh-index: 157

1,511 works95,028 citationsh-index: 131

Sherene Loi University of Melbourne

1,209 works78,425 citationsh-index: 126

Michael Untch MSB Medical School Berlin

1,412 works72,505 citationsh-index: 108

Abstract RF4-01: Central Nervous System Outcomes from the Phase III PATINA Trial (AFT-38)

Otto Metzger,S. J. Mandrekar,et al.

20260 citations

Abstract PS2-09-09: Early on-treatment PD-L1 expression and stromal tumor infiltrating lymphocytes (sTILs) refine the prediction of EFS in the NeoTRIP trial

Matteo Dugo,G. Viale,et al.

20260 citations

Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer

Otto Metzger,Sumithra Mandrekar,et al.

20263 citations

Role of ctDNA in predicting the outcome of patients with hormone receptor–positive, HER2-negative advanced breast cancer treated with first-line ribociclib and letrozole: BioItaLEE trial

Giampaolo Bianchini,Luca Malorni,et al.

20260 citations

Data associated with Longitudinal transcriptomic profiling identifies predictors of response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: results from the NeoTRIPaPDL1 trial

Dugo, Matteo,Huang, Chiun-Sheng,et al.

20250 citations